Literature DB >> 22527796

Diet intervention reduces uptake of αvβ3 integrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques.

Antti Saraste1, Iina Laitinen, Eliane Weidl, Moritz Wildgruber, Axel W Weber, Stephan G Nekolla, Gabriele Hölzlwimmer, Irene Esposito, Axel Walch, Pia Leppänen, Irina Lisinen, Peter B Luppa, Seppo Ylä-Herttuala, Hans-Jürgen Wester, Juhani Knuuti, Markus Schwaiger.   

Abstract

BACKGROUND: Expression of α(v)β(3) integrin has been proposed as a marker for atherosclerotic lesion inflammation. We studied whether diet intervention reduces uptake of α(v)β(3) integrin-targeted positron emission tomography tracer (18)F-galacto-RGD in mouse atherosclerotic plaques. METHODS AND
RESULTS: Hypercholesterolemic LDLR(-/-) ApoB(100/100) mice on high-fat diet for 4 months were randomized to further 3 months on high-fat diet (high-fat group, n = 8) or regular mouse chow (intervention group, n = 7). Intima-media ratio describing plaque burden was comparable between intervention and high-fat groups (2.0 ± 0.5 vs 2.3 ± 0.8, P = .5). Uptake of (18)F-galacto-RGD in the aorta was lower in the intervention than high-fat group (%ID/g 0.16 vs 0.23, P < .01). Autoradiography showed 35% lower uptake of (18)F-galacto-RGD in the atherosclerotic plaques in the intervention than high-fat group (P = .007). Uptake of (18)F-galacto-RGD in plaques correlated with uptake of (3)H-deoxyglucose and nuclear density, which was lower in the intervention than high-fat group (P = .01). Flow cytometry demonstrated macrophages expressing α(v) and β(3) integrins in the aorta.
CONCLUSIONS: Uptake of (18)F-galacto-RGD in mouse atherosclerotic lesions was reduced by lipid-lowering diet intervention. Expression of α(v)β(3) integrin is a potential target for evaluation of therapy response in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527796     DOI: 10.1007/s12350-012-9554-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  22 in total

1.  68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice.

Authors:  Seppo Ylä-Herttula; Juhani Knuuti; Anne Roivainen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

2.  Integrin-targeted imaging of inflammation in vascular remodeling.

Authors:  Mahmoud Razavian; Ravi Marfatia; Heloise Mongue-Din; Sina Tavakoli; Albert J Sinusas; Jiasheng Zhang; Lei Nie; Mehran M Sadeghi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-22       Impact factor: 8.311

3.  Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E.

Authors:  Yi Xin Wang; Baby Martin-McNulty; Ling Yuh Huw; Valdeci da Cunha; Joe Post; Josephine Hinchman; Ronald Vergona; Mark E Sullivan; William Dole; Katalin Kauser
Journal:  Atherosclerosis       Date:  2002-05       Impact factor: 5.162

4.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.

Authors:  Patrick M Winter; Anne M Morawski; Shelton D Caruthers; Ralph W Fuhrhop; Huiying Zhang; Todd A Williams; John S Allen; Elizabeth K Lacy; J David Robertson; Gregory M Lanza; Samuel A Wickline
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

5.  [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates.

Authors:  Roland Haubner; Bertrand Kuhnast; Christian Mang; Wolfgang A Weber; Horst Kessler; Hans-Jürgen Wester; Markus Schwaiger
Journal:  Bioconjug Chem       Date:  2004 Jan-Feb       Impact factor: 4.774

6.  Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.

Authors:  Carmen Burtea; Sophie Laurent; Oltea Murariu; Dirk Rattat; Gérard Toubeau; Alfons Verbruggen; David Vansthertem; Luce Vander Elst; Robert N Muller
Journal:  Cardiovasc Res       Date:  2008-01-03       Impact factor: 10.787

7.  Alpha-v beta-3 integrin expression in normal and atherosclerotic artery.

Authors:  M Hoshiga; C E Alpers; L L Smith; C M Giachelli; S M Schwartz
Journal:  Circ Res       Date:  1995-12       Impact factor: 17.367

8.  In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis.

Authors:  Stephen G Worthley; Zhuang Y Zhang; Josef Machac; Gérard Helft; Cheuk Tang; Gary Y H Liew; Azfar G Zaman; Matthew I Worthley; Zahi A Fayad; Monte S Buchsbaum; Valentin Fuster; Juan J Badimon
Journal:  Int J Cardiovasc Imaging       Date:  2008-11-01       Impact factor: 2.357

Review 9.  Arithmetic of vulnerable plaques for noninvasive imaging.

Authors:  Jagat Narula; Pankaj Garg; Stephan Achenbach; Sadako Motoyama; Renu Virmani; H William Strauss
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08

10.  Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.

Authors:  Iina Laitinen; Antti Saraste; Eliane Weidl; Thorsten Poethko; Axel W Weber; Stephan G Nekolla; Pia Leppänen; Seppo Ylä-Herttuala; Gabriele Hölzlwimmer; Axel Walch; Irene Esposito; Hans-Jürgen Wester; Juhani Knuuti; Markus Schwaiger
Journal:  Circ Cardiovasc Imaging       Date:  2009-05-13       Impact factor: 7.792

View more
  11 in total

1.  Specificity vs versatility: A fine balance for novel targeted molecular imaging radiotracers.

Authors:  James T Thackeray; Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2016-02-10       Impact factor: 5.952

2.  Atheroma and the inflammasome.

Authors:  H William Strauss
Journal:  J Nucl Cardiol       Date:  2015-02-20       Impact factor: 5.952

3.  PET/MR imaging of atherosclerosis: initial experience and outlook.

Authors:  Christoph Rischpler; Stephan G Nekolla; Ambros J Beer
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-09-19

4.  Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model.

Authors:  James T Thackeray; Jens P Bankstahl; Yong Wang; Mortimer Korf-Klingebiel; Almut Walte; Alexander Wittneben; Kai C Wollert; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-12       Impact factor: 9.236

Review 5.  Recent Advances in the Development of PET/SPECT Probes for Atherosclerosis Imaging.

Authors:  Yoichi Shimizu; Yuji Kuge
Journal:  Nucl Med Mol Imaging       Date:  2016-04-26

Review 6.  Novel Applications of Radionuclide Imaging in Peripheral Vascular Disease.

Authors:  Mitchel R Stacy; Albert J Sinusas
Journal:  Cardiol Clin       Date:  2015-10-17       Impact factor: 2.213

Review 7.  Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis.

Authors:  Soraya M Kazuma; Deborah Sultan; Yongfeng Zhao; Lisa Detering; Meng You; Hannah P Luehmann; Dulcineia S P Abdalla; Yongjian Liu
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 8.  Biological imaging of atherosclerosis: moving beyond anatomy.

Authors:  Johan W Verjans; Farouc A Jaffer
Journal:  J Cardiovasc Transl Res       Date:  2013-06-04       Impact factor: 4.132

Review 9.  Current and Emerging Preclinical Approaches for Imaging-Based Characterization of Atherosclerosis.

Authors:  Jonathan Vigne; James Thackeray; Jeroen Essers; Marcus Makowski; Zoreh Varasteh; Adelina Curaj; Angelos Karlas; Emmanuel Canet-Soulas; Willem Mulder; Fabian Kiessling; Michael Schäfers; René Botnar; Moritz Wildgruber; Fabien Hyafil
Journal:  Mol Imaging Biol       Date:  2018-12       Impact factor: 3.488

Review 10.  PET imaging of inflammation biomarkers.

Authors:  Chenxi Wu; Fang Li; Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2013-06-24       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.